User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 15 results.
    • Journal article
    Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA).
    Bachy, Emmanuel Camus, Vincent Thieblemont, Catherine Sibon, David Casasnovas, René-Olivier Ysebaert, Loïc Damaj, Gandhi Guidez, Stéphanie Pica, Gian Matteo Kim, Won Seog Lim, Soon Thye André, Marc[UCL] García-Sancho, Alejandro Martín Penarrubia, Maria Jesus Staber, Philipp B Trotman, Judith Hüttmann, Andreas Stefoni, Vittorio Re, Alessandro Gaulard, Philippe Delfau-Larue, Marie-Helene de Leval, Laurence Meignan, Michel Li, Ju Morschhauser, Franck Delarue, Richard (2022) Journal of clinical oncology — Vol. 40, no. 3, p. 242-251 (2022)
    • Journal article
    Development and Application of a Real-Time On-Line Blinded Independent Central Review of Interim Pet Scans to Determine Treatment Allocation in Lymphoma Trials
    Meignan, Michel Itti, Emmanuel Bardet, Stephane Lumbroso, Jean Edeline, Veronique Olivier, Pierre Vander Borght, Thierry[UCL] Reman, Oumedaly Karcher, Gilles Mundler, Olivier Mounier, Nicolas Ricci, Romain Federico, Massimo Raemaekers, John André, Marc (2009) Journal of Clinical Oncology — Vol. 27, no. 16, p. 2739-41 (2009)
    • Journal article
    High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: TMTV is a useful risk factor to stratify patients at baseline.
    Rossi, Cédric André, Marc[UCL] Dupuis, Jehan Morschhauser, Franck Joly, Bertrand Lazarovici, Julien Ghesquières, Hervé Stamatoullas, Aspasia Nicolas-Virelizier, Emmanuelle Feugier, Pierre Gac, Anne-Claire Moatti, Hannah Fornecker, Luc-Matthieu Deau, Bénédicte Joubert, Clémentine Fortpied, Catherine Raemaekers, John Federico, Massimo Kanoun, Salim Meignan, Michel Traverse-Glehen, Alexandra Cottereau, Anne-Ségolène Casasnovas, René-Olivier (2022) Haematologica — Vol. 107, no. 12, p. 2897-2904 (2022)
    • Journal article
    Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.
    André, Marc[UCL] Girinsky, Théodore Federico, Massimo Reman, Oumédaly Fortpied, Catherine Gotti, Manuel Casasnovas, Olivier Brice, Pauline van der Maazen, Richard Re, Alessandro Edeline, Véronique Fermé, Christophe van Imhoff, Gustaaf Merli, Francesco Bouabdallah, Réda Sebban, Catherine Specht, Lena Stamatoullas, Aspasia Delarue, Richard Fiaccadori, Valeria Bellei, Monica Raveloarivahy, Tiana Versari, Annibale Hutchings, Martin Meignan, Michel Raemaekers, John (2017) Journal of Clinical Oncology — Vol. 35, no. 16, p. 1786-1794 (2017)
    • Journal article
    Reply to J.A. Vargo et al, H.J.A. Adams et al, E. Hindié et al, and S. Kothari et al.
    André, Marc[UCL] Federico, Massimo Fortpied, Catherine Girinsky, Théodore Meignan, Michel Raemaekers, John (2017) Journal of Clinical Oncology — Vol. 35, no. 24, p. 2853-2854 (2017)
    • Journal article
    Prognostic value of baseline metabolic tumor volume in early stage Hodgkin's lymphoma in the standard arm of H10 trial.
    Cottereau, Anne Ségolène Versari, Annibale Loft, Annika Casasnovas, Olivier Bellei, Monica Ricci, Romain Bardet, Stéphane Castagnoli, Antonio Brice, Pauline Raemaekers, John Deau, Bénédicte Fortpied, Catherine Raveloarivahy, Tiana Van Zele, Emelie Chartier, Loic Vander Borght, Thierry[UCL] Federico, Massimo Hutchings, Martin Ricardi, Umberto André, Marc[UCL] Meignan, Michel (2018) Blood — Vol. 131, no. 13, p. 1456-1463 (2018)
    • Journal article
    PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study.
    Casasnovas, René-Olivier Bouabdallah, Reda Brice, Pauline Lazarovici, Julien Ghesquieres, Hervé Stamatoullas, Aspasia Dupuis, Jehan Gac, Anne-Claire Gastinne, Thomas Joly, Bertrand Bouabdallah, Krimo Nicolas-Virelizier, Emmanuelle Feugier, Pierre Morschhauser, Franck Delarue, Richard Farhat, Hassan Quittet, Philippe Berriolo-Riedinger, Alina Tempescul, Adrian Edeline, Véronique Maisonneuve, Hervé Fornecker, Luc-Matthieu Lamy, Thierry Delmer, Alain Dartigues, Peggy Martin, Laurent André, Marc[UCL] Mounier, Nicolas Traverse-Glehen, Alexandra Meignan, Michel (2019) The Lancet. Oncology — Vol. 20, no. 2, p. 202-2015 (2019)
    • Journal article
    PET-guided, BEACOPP therapy in advanced Hodgkin lymphoma - Authors' reply.
    Casasnovas, René-Olivier Bouabdallah, Reda Brice, Pauline Lazarovici, Julien Ghesquieres, Hervé Stamatoullas, Aspasia Berriolo-Riedinger, Alina Fornecker, Luc-Matthieu André, Marc[UCL] Meignan, Michel (2019) The Lancet. Oncology — Vol. 20, no. 4, p. e190 (2019)
    • Journal article
    Deep Learning Approach to Automatize TMTV Calculations Regardless of Segmentation Methodology for Major FDG-Avid Lymphomas.
    Revailler, Wendy Cottereau, Anne Ségolène Rossi, Cedric Noyelle, Rudy Trouillard, Thomas Morschhauser, Franck Casasnovas, Olivier Thieblemont, Catherine Gouill, Steven Le André, Marc[UCL] Ghesquieres, Herve Ricci, Romain Meignan, Michel Kanoun, Salim (2022) Diagnostics — Vol. 12, no. 2, p. 417 [1-12] (2022)
    • Journal article
    Positron Emission Tomography-Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association Study.
    Casasnovas, René-Olivier Bouabdallah, Reda Brice, Pauline Lazarovici, Julien Ghesquieres, Hervé Stamatoullas, Aspasia Dupuis, Jehan Gac, Anne-Claire Gastinne, Thomas Joly, Bertrand Bouabdallah, Krimo Nicolas-Virelizier, Emmanuelle Feugier, Pierre Morschhauser, Franck Sibon, David Bonnet, Christophe Berriolo-Riedinger, Alina Edeline, Véronique Parrens, Marie Damotte, Diane Coso, Diane André, Marc[UCL] Meignan, Michel Rossi, Cédric (2022) Journal of clinical oncology — Vol. 40, no. 10, p. 1091-1101 (2022)
    • Journal article
    FDG-PET driven consolidation strategy in diffuse large B-cell lymphoma: Final results of a randomized phase II study.
    Casasnovas, Rene-Olivier Ysebaert, Loic Thieblemont, Catherine Bachy, Emmanuel Feugier, Pierre Delmer, Alain Tricot, Sabine Gabarre, Jean André, Marc[UCL] Fruchart, Christophe Mounier, Nicolas Delarue, Richard Meignan, Michel Berriolo-Riedinger, Alina Bardet, Stephane Emile, Jean-Francois Jais, Jean-Philippe Haioun, Corinne Tilly, Herve Morschhauser, Franck (2017) Blood — Vol. 130, no. 11, p. 1315-1326 (2017)
    • Journal article
    Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study.
    Bachy, Emmanuel Houot, Roch Feugier, Pierre Bouabdallah, Krimo Bouabdallah, Reda Virelizier, Emmanuelle Nicolas Maerevoet, Marie Fruchart, Christophe Snauwaert, Sylvia Le Gouill, Steven Marolleau, Jean-Pierre Molina, Lysiane Moluçon-Chabrot, Cécile Thieblemont, Catherine Tilly, Hervé Bijou, Fontanet Haioun, Corinne Van Den Neste, Eric[UCL] Fabiani, Bettina Meignan, Michel Cartron, Guillaume Salles, Gilles Casasnovas, Olivier Morschhauser, Franck (2022) Blood — Vol. 139, no. 15, p. 2338-2346 (2022)
    • Journal article
    Report of the 6th International Workshop on PET in lymphoma.
    Nanni, Cristina Cottereau, Anne Ségolène Lopci, Egesta Bodet-Milin, Caroline Coronado, Monica Pro, Barbara Kim, Wong Seog Trotman, Judith Barrington, Sally Duhrsen, Ulrich Vander Borght, Thierry[UCL] Zamagni, Elena Kraeber-Bodéré, Françoise Messiou, Christina Rahmouni, Alain Buvat, Irène André, Marc[UCL] Hertzberg, Mark Oyen, Wim Casasnovas, Olivier Luminari, Stefano Garderet, Laurent Montravers, Françoise Kobe, Carsten Kluge, Regine Versari, Annibale Zucca, Emanuele Moreau, Philippe Cheson, Bruce Haioun, Corinne Gallamini, Andrea Meignan, Michel (2017) Leukemia and Lymphoma — Vol. 58, no. 10, p. 2298-2303 (2017)
    • Journal article
    Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial
    Raemaekers, John M M André, Marc[UCL] Federico, Massimo Girinsky, Theodore Oumedaly, Reman Brusamolino, Ercole Brice, Pauline Fermé, Christophe van der Maazen, Richard Gotti, Manuel Bouabdallah, Reda Sebban, Catherine J Lievens, Yolande Re, Allessandro Stamatoullas, Aspasia Morschhauser, Frank Lugtenburg, Pieternella J Abruzzese, Elisabetta Olivier, Pierre Casasnovas, Rene-Olivier van Imhoff, Gustaaf Raveloarivahy, Tiana Bellei, Monica Vander Borght, Thierry[UCL] Bardet, Stephane Versari, Annibale Hutchings, Martin Meignan, Michel Fortpied, Catherine (2014) Journal of Clinical Oncology — Vol. 32, no.12, p. 1188-1194 (2014)
    • Journal article
    Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial.
    Fornecker, Luc-Matthieu Lazarovici, Julien Aurer, Igor Casasnovas, René-Olivier Gac, Anne-Claire Bonnet, Christophe Bouabdallah, Krimo Feugier, Pierre Specht, Lena Molina, Lysiane Touati, Mohamed Borel, Cécile Stamatoullas, Aspasia Nicolas-Virelizier, Emmanuelle Pascal, Laurent Lugtenburg, Pieternella Di Renzo, Nicola Vander Borght, Thierry[UCL] Traverse-Glehen, Alexandra Dartigues, Peggy Hutchings, Martin Versari, Annibale Meignan, Michel Federico, Massimo André, Marc[UCL] LYSA-FIL-EORTC Intergroup (2023) Journal of clinical oncology — Vol. 41, no. 2, p. 327-335 (2023)